Incidence of hypertension in Korea: 5-year follow-up study

Journal of Korean Medical Science

Volumn 26, Issue 10, 2011, Pages 1286-1292

  Lee, Jang Hoon ^a   Yang, Dong Heon ^a   Park, Hun Sik ^a   Cho, Yongkeun ^a   Jun, Jae Eun ^a   Park, Wee Hyun ^a   Chun, Byung Yeol ^a   Shin, Ji Yeon ^a   Shin, Dong Hoon ^b   Lee, Kyeong Soo ^c   Kim, Kee Sik ^d   Kim, Kwon Bae ^e   Kim, Young Jo ^f   Chae, Shung Chull ^a   An, Moon Young ^g   Choi, Ji Yong ^g   Ha, Sung Woo ^g   Hong, Nam Soo ^g   Hur, Seung Ho ^g   Hwang, Jun Hyun ^g   Hwang, Tae Yoon ^g   Jin, Soo Hee ^g   Jung, Eui Dal ^g   Kam, Sin ^g   Kim, Bo Wan ^g   Kim, Hye Soon ^g   Kim, Jong Yeon ^g   Kim, Jung Guk ^g   Kim, Keon Yeop ^g   Kim, Ki Su ^g   Lee, Duk Hee ^g   Lee, Hyoung Woo ^g   Lee, In Kyu ^g   Lee, Jung Jeung ^g   Lee, Kyung Eun ^g   Lee, Mi Young ^g   Lee, Sang Hee ^g   Lim, Bu Dol ^g   Lim, Ji Seun ^g   Nam, Chang Wook ^g   Park, Keun Gyu ^g   Park, Sun Kyun ^g   Ryu, Jae Kean ^g   Shin, Dong Gu ^g   Shon, Ho Sang ^g   Son, Hyo Kyung ^g   Won, Kyu Chang ^g   Yang, Jin Hoon ^g   Yu, Gyeong Im ^g   more..

^a Kyungpook National University School of Medicine   (South Korea)

^b Keimyung University School of Medicine   (South Korea)

^c Yeungnam University College of Medicine   (South Korea)

^d Catholic University of Daegu   (South Korea)

^e Dongsan Medical Center   (South Korea)

^f Young Nam University Hospital   (South Korea)

^g NONE

Author keywords

Blood pressure; Hypertension; Incidence; Population

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGE; AGED; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; COHORT ANALYSIS; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; INCIDENCE; MALE; MIDDLE AGED; MORPHOMETRICS; PATHOPHYSIOLOGY; QUESTIONNAIRE; RISK FACTOR; SOUTH KOREA;

ADULT; AGE FACTORS; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; BODY WEIGHTS AND MEASURES; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; INCIDENCE; MALE; MIDDLE AGED; QUESTIONNAIRES; REPUBLIC OF KOREA; RISK FACTORS;

EID: 84863012203     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2011.26.10.1286     Document Type: Article

References (29)

1. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003; 289: 2560-72.
2. Rodriguez BL, Labarthe DR, Huang B, Lopez-Gomez J. Rise of blood pressure with age: new evidence of population differences. Hypertension 1994; 24: 779-85.
3. Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, Horan MJ, Labarthe D. Prevalence of hypertension in the US adult population: results from the third national health and nutrition examination survey, 1988-1991. Hypertension 1995; 25: 305-13.
4. D'Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008; 117: 743-53.
5. Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Ford CE, Shulman NB, Stamler J. Blood pressure and end-stage renal disease in men. N Engl J Med 1996; 334: 13-8.
6. Stokes J 3rd, Kannel WB, Wolf PA, D'Agostino RB, Cupples LA. Blood pressure as a risk factor for cardiovascular disease. The Framingham Study:30 years of follow-up. Hypertension 1989; 13(5 Suppl): I13-8.
7. Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJ; Comparative Risk Assessment Collaborating Group. Selected major risk factors and global and regional burden of disease. Lancet 2002; 360: 1347-60.
8. Kearney PM, Whelton M, Reynolds K, Whelton PK, He J. Worldwide prevalence of hypertension: a systematic review. J Hypertens 2004; 22: 11-9.
9. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365: 217-23.
10. Pereira M, Lunet N, Azevedo A, Barros H. Differences in prevalence, awareness, treatment and control of hypertension between developing and developed countries. J Hypertens 2009; 27: 963-75.
11. Cornoni-Huntley J, LaCroix AZ, Havlik RJ. Race and sex differentials in the impact of hypertension in the United States. The National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study. Arch Intern Med 1989; 149: 780-8.
12. Kannel WB, Garrison RJ, Dannenberg AL. Secular blood pressure trends in normotensive persons: the Framingham Study. Am Heart J 1993; 125:1154-8.
13. Vasan RS, Larson MG, Leip EP, Kannel WB, Levy D. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet 2001; 358: 1682-6.
14. Population Division of the Department of Economic and Social Affairs of the United Nations Secretariat. World population prospects: the 2008 revision. New York: UN Secretariat, 2009.
15. Le CN. "Population Statistics & Demographics" Asian-Nation: The Landscape of Asian America. Available at http://www.asian-nation.org/population. shtml [accessed 16 June, 2010].
16. Kim JS, Jones DW, Kim SJ, Hong YP. Hypertension in Korea: a national survey. Am J Prev Med 1994; 10: 200-4.
17. Jo I, Ahn Y, Lee J, Shin KR, Lee HK, Shin C. Prevalence, awareness, treatment, control and risk factors of hypertension in Korea: the Ansan study. J Hypertens 2001; 19: 1523-32.
18. Burt VL, Cutler JA, Higgins M, Horan MJ, Labarthe D, Whelton P, Brown C, Roccella EJ. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population: data from the health examination surveys, 1960 to 1991. Hypertension 1995; 26: 60-9.
19. Kastarinen MJ, Salomaa VV, Vartiainen EA, Jousilahti PJ, Tuomilehto JO, Puska PM, Nissinen AM. Trends in blood pressure levels and control of hypertension in Finland from 1982 to 1997. J Hypertens 1998; 16: 1379-87.
20. Wu X, Duan X, Gu D, Hao J, Tao S, Fan D. Prevalence of hypertension and its trends in Chinese populations. Int J Cardiol 1995; 52: 39-44.
21. Kinsella K, He W. U.S. Census Bureau, International Population Reports, P95/09-1, An Aging World: 2008. Washington DC: U.S. Government Printing Office, 2009.
22. Kim J, Kim E, Yi H, Joo S, Shin K, Kim J, Kimm K, Shin C. Short-term incidence rate of hypertension in Korea middle-aged adults. J Hypertens 2006; 24: 2177-82.
23. Sekikawa A, Kuller LH, Ueshima H, Park JE, Suh I, Jee SH, Lee HK, Pan WH. Coronary heart disease mortality trends in men in the post World War II birth cohorts aged 35-44 in Japan, South Korea and Taiwan compared with the United States. Int J Epidemiol 1999; 28: 1044-9.
24. Hong KS. Prehypertension. Korean Circ J 2008; 38: 1-6.
25. Kim YM, Hong KS, Choi YH, Choi MG, Jeong JY, Lee JM, Kim DH. Rates and related factors of progression to hypertension among prehypertensive local residents aged 45 or over in Chuncheon City: Hallym Aging Study from a Community-Based Cross-Sectional Study. Korean Circ J 2008; 38:43-50.
26. Natali A, Muscelli E, Casolaro A, Nilsson P, Melander O, Lalic N, Ferrannini E, Petrie JR. Metabolic characteristics of prehypertension: role of classification criteria and gender. J Hypertens 2009; 27: 2394-402.
27. Perry HM Jr, Miller JP. Difficulties in diagnosing hypertension: implications and alternatives. J Hypertens 1992; 10: 887-96.
28. Weissfeld JL, Kuller LH. Methodologic evaluation of incidence rates for hypertension: calculated for Pittsburgh's MRFIT usual care men. J Chronic Dis 1985; 38: 915-25.
29. Kristman V, Manno M, Côté P. Loss to follow-up in cohort studies: how much is too much? Eur J Epidemiol 2004; 19: 751-60.